Consilient Health Ltd.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Consilient Health Ltd.
Newly public Aligos will team with Merck & Co. on oligonucleotide therapies for NASH. Maze Therapeutics launches ophthalmology and CV-focused spinouts with Alloy and BridgeBio.
The US green light for Alkindi is a big step for the UK biotech in its bid to become a world-leading specialty endocrinology business.
- Group Purchasing
- Home Infusion
- Generic Drugs